PATENT CLAIM ANALYSIS

Application Number: 15946070
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "453000"]

Abstract:
Clostridium difficile  infects and kills 30,000-40,000 people a year in the United States. Provided herein are methods to inhibit growth and reduce the spread of  C. difficile  using puupehenone, a natural marine product that is excreted from some species of sponges and coral as a defense mechanism.

Claim (Index 14):
The method of  claim 11 , wherein the  Clostridium  infection is a  C. perfingens  infection,  C. difficile  infection,  C. tetani  infection or a  C. botulinum  infection.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 91.0
- Lexical Diversity: 1.19048
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15576220', '15517191', '13021184', '12357077', '15831237']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7434794619848987
- 35 USC 102 Novelty (BERT): 0.4912658596061477
- Combined Prediction Score: 0.7182581017470236
- Mean Citation Score: 134.85382599999997
- Max Citation Score: 139.80746000000002
- Similarity Product: 85.85739160815717

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test